title: Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
abstract: We recently developed a nutritional model of steatohepatitis and metabolic syndrome in Ossabaw pigs. Here we describe changes in the serum proteome of pigs fed standard chow (control group; n = 7), atherogenic diet (n = 5), or modified atherogenic diet (M-ath diet group; n = 6). Pigs fed atherogenic diet developed metabolic syndrome and mildly abnormal liver histology, whereas pigs fed M-ath diet exhibited severe metabolic syndrome and liver injury closely resembling human nonalcoholic steatohepatitis (NASH). Using a label-free mass spectrometry-based proteomics approach, we identified 1,096 serum proteins, 162 of which changed significantly between any two diet groups (false discovery rate <5%). Biological classification of proteins with significant changes revealed functions previously implicated in development of NASH in humans, including immune system regulation and inflammation (orosomucoid 1, serum amyloid P component, paraoxonase 1, protein similar to alpha-2-macroglobulin precursor, beta-2-microglobulin, p101 protein, and complement components 2 and C8G), lipid metabolism (apolipoproteins C-III, E, E precursor, B, and N), structural and extracellular matrix proteins (transthyretin and endopeptidase 24.16 type M2), and coagulation [carboxypeptidase B2 (plasma)]. Several proteins with significant differential expression in pigs were also identified in our recent human proteomics study as changing significantly in serum from patients across the spectrum of nonalcoholic fatty liver disease, including apolipoproteins C-III and B, orosomucoid 1, serum amyloid P component, transthyretin, paraoxonase 1, and a protein similar to alpha-2-macroglobulin precursor. This serum proteomic analysis provides additional information about the pathogenesis of NASH and further characterizes our large animal model of diet-induced steatohepatitis and metabolic syndrome in Ossabaw pigs.
authors.affiliation: Indiana Univ. School of Medicine, Indianapolis, 46202, USA.
authors.forename: Lauren N
authors.initials: LN
authors.lastname: Bell
authors.forename: Lydia
authors.initials: L
authors.lastname: Lee
authors.forename: Romil
authors.initials: R
authors.lastname: Saxena
authors.forename: Kerry G
authors.initials: KG
authors.lastname: Bemis
authors.forename: Mu
authors.initials: M
authors.lastname: Wang
authors.forename: Janice L
authors.initials: JL
authors.lastname: Theodorakis
authors.forename: Raj
authors.initials: R
authors.lastname: Vuppalanchi
authors.forename: Mouhamad
authors.initials: M
authors.lastname: Alloosh
authors.forename: Michael
authors.initials: M
authors.lastname: Sturek
authors.forename: Naga
authors.initials: N
authors.lastname: Chalasani
mesh_terms: D000818:Animals; D004036:Diet, Atherogenic; D005234:Fatty Liver / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood*; D023421:Models, Animal; D040901:Proteomics; D013552:Swine; D013556:Swine, Miniature / Q000097:blood*